IGFBP5 and neoplasm: Moreover, both lentivirus-mediated IGFBP5 knockdown and nanocapsule-mediated Cas9/sgIGFBP5 delivery significantly compromise GSC invasion and extend the survival of orthotopic tumor-bearing mice.